Article metrics

Download PDFPDF

Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

 

Online download statistics by month:

Online download statistics by month: May 2020 to September 2022

AbstractFullPdf
May 2020614609228
Jun 2020395388106
Jul 2020606622214
Aug 2020343343123
Sep 2020233228147
Oct 2020209207100
Nov 202020820658
Dec 202015815771
Jan 202117116662
Feb 202116315548
Mar 202119819472
Apr 202117016473
May 202116415853
Jun 202116416164
Jul 202115815165
Aug 202114814466
Sep 202115314460
Oct 202118518459
Nov 202113412756
Dec 202110210143
Jan 202216216553
Feb 202218117538
Mar 202214314143
Apr 202218919139
May 202216516247
Jun 202216716246
Jul 202212112248
Aug 202214013743
Sep 202222722233
Total617160862158